Suppr超能文献

探讨精神分裂症外显子组评分与精神分裂症、兄弟姐妹和健康对照者功能的相关性:EUGEI 研究结果。

Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study.

机构信息

Department of Psychiatry, University of Health Sciences Ankara Diskapi Training and Research Hospital, Ankara, Turkey.

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.

出版信息

Eur Psychiatry. 2021 Mar 19;64(1):e25. doi: 10.1192/j.eurpsy.2021.19.

Abstract

BACKGROUND

A cumulative environmental exposure score for schizophrenia (exposome score for schizophrenia [ES-SCZ]) may provide potential utility for risk stratification and outcome prediction. Here, we investigated whether ES-SCZ was associated with functioning in patients with schizophrenia spectrum disorder, unaffected siblings, and healthy controls.

METHODS

This cross-sectional sample consisted of 1,261 patients, 1,282 unaffected siblings, and 1,525 healthy controls. The Global Assessment of Functioning (GAF) scale was used to assess functioning. ES-SCZ was calculated based on our previously validated method. The association between ES-SCZ and the GAF dimensions (symptom and disability) was analyzed by applying regression models in each group (patients, siblings, and controls). Additional models included polygenic risk score for schizophrenia (PRS-SCZ) as a covariate.

RESULTS

ES-SCZ was associated with the GAF dimensions in patients (symptom: B = -1.53, p-value = 0.001; disability: B = -1.44, p-value = 0.001), siblings (symptom: B = -3.07, p-value < 0.001; disability: B = -2.52, p-value < 0.001), and healthy controls (symptom: B = -1.50, p-value < 0.001; disability: B = -1.31, p-value < 0.001). The results remained the same after adjusting for PRS-SCZ. The degree of associations of ES-SCZ with both symptom and disability dimensions were higher in unaffected siblings than in patients and controls. By analyzing an independent dataset (the Genetic Risk and Outcome of Psychosis study), we replicated the results observed in the patient group.

CONCLUSIONS

Our findings suggest that ES-SCZ shows promise for enhancing risk prediction and stratification in research practice. From a clinical perspective, ES-SCZ may aid in efforts of clinical characterization, operationalizing transdiagnostic clinical staging models, and personalizing clinical management.

摘要

背景

精神分裂症的累积环境暴露评分(精神分裂症暴露组评分[ES-SCZ])可能为风险分层和预后预测提供潜在效用。在这里,我们研究了 ES-SCZ 是否与精神分裂症谱系障碍患者、未受影响的兄弟姐妹和健康对照者的功能有关。

方法

本横断面样本包括 1261 名患者、1282 名未受影响的兄弟姐妹和 1525 名健康对照者。使用总体功能评估量表(GAF)来评估功能。ES-SCZ 是根据我们之前验证过的方法计算的。在每个组(患者、兄弟姐妹和对照组)中,应用回归模型分析 ES-SCZ 与 GAF 维度(症状和残疾)之间的关系。另外的模型还包括精神分裂症多基因风险评分(PRS-SCZ)作为协变量。

结果

ES-SCZ 与患者(症状:B=-1.53,p 值=0.001;残疾:B=-1.44,p 值=0.001)、兄弟姐妹(症状:B=-3.07,p 值<0.001;残疾:B=-2.52,p 值<0.001)和健康对照组(症状:B=-1.50,p 值<0.001;残疾:B=-1.31,p 值<0.001)的 GAF 维度有关。调整 PRS-SCZ 后,结果仍然相同。在未受影响的兄弟姐妹中,ES-SCZ 与症状和残疾维度的关联程度均高于患者和对照组。通过分析一个独立的数据集(遗传风险和精神病结果研究),我们复制了在患者组中观察到的结果。

结论

我们的研究结果表明,ES-SCZ 有望提高研究实践中的风险预测和分层能力。从临床角度来看,ES-SCZ 可能有助于临床特征描述、实施跨诊断临床分期模型和个性化临床管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4073/8080213/180d3ae9bc43/S0924933821000195_fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验